Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins
Open Access
- 1 March 1988
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (3), 254-258
- https://doi.org/10.1038/bjc.1988.55
Abstract
We have examined the ability of a series of non- or minimally-immunosuppressive analogues of cyclosporin A to modify cytotoxic drug resistance in vitro. The series includes both cyclosporins derived from naturally-occurring compounds and synthetic cyclosporins. In contrast to our previous findings, we now report that several of these analogues are highly effective modifiers of resistance to adriamycin and vincristine in a multidrug resistant subline of the human small cell lung cancer cell line NCI-H69. Two of the analogues (W8-032 and B3-243) maintain considerable activity in the dose range 1-2 micrograms ml-1 whereas little activity remains for cyclosporin A when the dose is reduced to this level. B3-243, however, in contrast to cyclosporin A and W8-032, does itself show growth inhibitory effects in this dose range. Possible clinical trial of these cyclosporins as resistance modifiers will depend upon their in vivo toxicology and pharmacokinetic properties.Keywords
This publication has 14 references indexed in Scilit:
- A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivityBritish Journal of Cancer, 1987
- Drug resistance in human lung cancer cell lines: Cross-resistance studies and effects of the calcium transport blocker, verapamilInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinomaBritish Journal of Cancer, 1986
- Rapid chemosensitivity testing of human lung tumor cells using the MTT assayCancer Chemotherapy and Pharmacology, 1986
- Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cellsBritish Journal of Cancer, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.JCI Insight, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites CarcinomaJCI Insight, 1982
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- OVERCOMING OF VINCRISTINE RESISTANCE IN P388 LEUKEMIA INVIVO AND INVITRO THROUGH ENHANCED CYTO-TOXICITY OF VINCRISTINE AND VINBLASTINE BY VERAPAMIL1981